Patrick P. Den Boer — President and CEO
Pat Den Boer founded QPharma in 1994 and remains its President and Chief Executive Officer, responsible for strategy, business development, and day-to-day management of the company. An industry-recognized expert in system validation, PDMA compliance, and sales force automation, Pat previously served in roles that included positions at Warner-Lambert and Lederle Laboratories.
Pat received a B.S. in Chemical Biology from Stevens Institute of Technology and an M.S. in Software Engineering from Iona College.
Reno Amadori — Chief Financial Officer
Reno Amadori serves as Chief Financial Officer at QPharma, with responsibility for the company’s financial activities and operations, including budgeting, accounting, and planning. He also oversees the company’s Human Resources and Facilities Management functions. Reno has played a valued role in the company for more than 16 years.
Prior to joining QPharma, Reno spent nine years with Cendant Corporation. In addition to his work with QPharma, Reno serves as a volunteer firefighter.
John Cunningham — Executive Vice President of Sales and Marketing
John Cunningham serves as Executive Vice President of Sales at QPharma. A veteran life sciences sales executive and entrepreneur, John is responsible for new business as well as growth and development in current accounts.
John’s previous experience includes senior sales positions at companies that include MediMedia USA and Cegedim Relationship Management. He holds marketing degrees from Florida Atlantic University and Arkansas State University.
Dawn L. Gabriel, Ph.D. — Chief Compliance Officer
Dr. Dawn Gabriel is the Chief Compliance Officer at QPharma, where she oversees compliance for internal operations, including Quality Systems, computer systems validation, and licensing, and plays a leadership role in providing compliance consulting for QPharma’s life sciences clients.
Dawn previously served at Johnson & Johnson, most recently in the position of Senior Director, R&D Quality and Compliance. Dawn earned a B.S. in Chemistry from Fairfield University and a doctorate in Pharmaceutics from the University of Connecticut.
Brendan Middleton — Director of Marketing and Public Relations
Brendan Middleton is the Director of Marketing and Public Relations at QPharma, responsible for the firm’s corporate communications, media relations, and business development, as well as marketing activities for key clients. He previously spent more than seven years with Saint Michael’s Medical Center in Newark, most recently as Director of Communications and Public Affairs.
Brendan earned a B.A. from Kean University. In 2012, he was named a Fellow of the Robert Wood Johnson Foundation.
Lori Peters – Senior Vice President, Commercial Operations
Lori Peters serves as Senior Vice President, Commercial Operations at QPharma. In this role, she oversees client implementations and day-to-day operations within the company’s Commercial Services group, with responsibility for solutions that include sample management, fulfillment, product launch services, Key Opinion Leader (KOL) engagement, and training.
A subject matter expert on life sciences product launches and commercialization, as well as KOL engagement, Lori joined QPharma with the acquisition of Qforma, where she served in various senior positions over several years. She holds a business degree from Berkeley College.
Jonathan Wright, Esq., LL.M. — Chief Legal Officer and General Counsel
Jonathan Wright, Esq. serves as QPharma’s Chief Legal Officer and General Counsel, overseeing the firm’s legal matters, including mergers and acquisitions and contracts. He also applies his healthcare compliance expertise to QPharma with respect to its engagements with the firm’s health and life sciences clients.
Jonathan previously served as In-House Staff Attorney for a national hospice provider headquartered in New Jersey. He attained his J.D. from Florida A&M University College of Law and earned a B.A. in Russian Language from the University of Michigan. He holds an LL.M. in Health and Pharmaceutical Law from Seton Hall University School of Law and is a graduate of Seton Hall’s U.S. Healthcare Compliance Certification program; and is presently pursuing his Executive MBA in Healthcare and Pharmaceutical Marketing from Saint Joseph’s University.